HIGHLIGHTS
- who: Angela Genchi from the (UNIVERSITY) have published the paper: Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study, in the Journal: (JOURNAL) of 17/Oct/2022
- what: The aim of the study was to evaluate the feasibility, safety and tolerability of intrathecally administered hfNPCs in patients with PMS. The study showed that hfNPC therapy in PMS is feasible, safe and tolerable.
- how: The results are in line with previous evidence in murine models of Alzheimer`s disease showing that NPC transplantation reduced memory deficits through . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.